期刊
CANCER LETTERS
卷 371, 期 2, 页码 347-353出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2015.11.032
关键词
Glucose metabolism; Glycosylation; ER stress; Ovarian cancer; Resveratrol
类别
资金
- Priority Research Centers Program [2009-0093820]
- BK21 plus program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [5256-20140100]
- National Institutes of Health [CA116984]
- NATIONAL CANCER INSTITUTE [R01CA116984] Funding Source: NIH RePORTER
Malignant tumors have a high glucose demand and alter cellular metabolism to survive. Herein, focusing on the utility of glucose metabolism as a therapeutic target, we found that resveratrol induced endoplasmic reticulum (ER) stress-mediated apoptosis by interrupting protein glycosylation in a cancer specific manner. Our results indicated that resveratrol suppressed the hexosamine biosynthetic pathway and interrupted protein glycosylation through GSK3 beta activation. Application of either biochemical intermediates of the hexosamine pathway or small molecular inhibitors of GSK3 beta reversed the effects of resveratrol on the disruption of protein glycosylation. Additionally, an ER UDPase, ectonucleoside triphosphate diphosphohydrolase 5 (ENTPD5), modulated protein glycosylation by Akt attenuation in response to resveratrol. By inhibition or overexpression of Akt functions, we confirmed that the glycosylation activities were dependent on ENTPD5 expression and regulated by the action of Akt in ovarian cancer cells. Resveratrol-mediated disruption of protein glycosylation induced cellular apoptosis as indicated by the up-regulation of GADD153, followed by the activation of ER-stress sensors (PERK and ATF6 alpha). Thus, our results provide novel insight into cancer cell metabolism and protein glycosylation as a therapeutic target for cancers. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据